Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,889 | -63,189 | -44,934 | -22,290 | -116,045 |
| Depreciation Amortization | 5,089 | 4,763 | 3,540 | 1,521 | 1,198 |
| Accounts receivable | -236 | -1,687 | -146 | -1,072 | 1,968 |
| Accounts payable and accrued liabilities | -1,311 | -588 | 705 | -168 | -414 |
| Other Working Capital | 39,909 | 34,525 | 2,223 | 113 | 7,130 |
| Other Operating Activity | 19,166 | 13,393 | 8,323 | 5,095 | 27,399 |
| Operating Cash Flow | $-19,272 | $-12,783 | $-30,289 | $-16,801 | $-78,764 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,896 | -11,438 | -11,283 | -8,745 | -17,948 |
| Purchase Of Investment | -209,629 | -141,008 | -55,016 | N/A | -307,282 |
| Sale Of Investment | 262,872 | 190,497 | 130,833 | 77,648 | 383,465 |
| Investing Cash Flow | $40,347 | $38,051 | $64,534 | $68,903 | $58,235 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 145 | 94 | 94 | 94 | 147 |
| Other Financing Activity | -26,763 | -18,391 | -11,967 | -5,080 | -27,773 |
| Financing Cash Flow | $-26,618 | $-18,297 | $-11,873 | $-4,986 | $-27,626 |
| Beginning Cash Position | 41,201 | 41,201 | 41,201 | 41,201 | 89,356 |
| End Cash Position | 35,658 | 48,172 | 63,573 | 88,317 | 41,201 |
| Net Cash Flow | $-5,543 | $6,971 | $22,372 | $47,116 | $-48,155 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,272 | -12,783 | -30,289 | -16,801 | -78,764 |
| Capital Expenditure | -12,896 | -11,438 | -11,283 | -8,745 | -17,948 |
| Free Cash Flow | -32,168 | -24,221 | -41,572 | -25,546 | -96,712 |